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Our laboratory focuses on the well-known tumor suppressor gene Phosphatase and tensin 
homolog (PTEN), lost in many cancers due to genetic or epigenetic changes. Importantly, 
reduced PTEN protein level, but not mRNA level correlates with poor outcome in some cancers, 
such as breast carcinoma. This suggests that post-translational mechanisms regulating PTEN 
protein stability could play a key role in disease progression.
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 The signaling pathways, 
components, and physiological conditions that regulate PTEN protein stability are not well 
studied and remain a major challenge in the field. Our laboratory undertook a global shRNA 
screen to identify factors that negatively regulate PTEN protein stability to understand the basic 
mechanism that regulates PTEN protein stability. One such factor that was identified in the 
shRNA screen is Ubiquitin Conjugating Enzyme E2K (UbE2K). As PTEN plays a critical role in 
regulating cellular homeostasis, it will be important to elucidate how PTEN protein turnover is 




PTEN is a well-known tumor suppressor gene that possesses dual lipid and protein 
phosphatase activity. It is known that lipid phosphatase activity is directly associated with the 
role PTEN has as a tumor suppressor, while the importance of the protein phosphatase activities 
are gradually unraveling. PTEN regulates multiple cellular processes such as cell polarity and 
migration, growth and metabolism, cell-cycle progression.
2
 PTEN dephosphorylates 
phosphatidylinosital (3,4,5)-triphosphate (PIP3) to PIP2, thus antagonizing the AKT pathway, as 
PIP3 normally activates AKT and its downstream signaling pathway. AKT activation promotes 
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cell survival, proliferation, growth, and glycogen metabolism (Fig. 1). PTEN is highly mutated in 
many cancers, and it has been suggested that genomic and non-genomic events lead to PTEN 





PTEN activity is regulated by many different mechanisms such as posttranslational 
modifications (including phosphorylation and ubiquitination), protein-protein interactions, 




PTEN (Fig. 2) is phosphorylated at its C2 domain, which upregulates PTEN activity and 
protein stability through increased membrane targeting and reduced polyubiquitination, 
respectively. PTEN is also phosphorylated at the C-tail domain, which inhibits the catalytic 
activity of PTEN and stabilizes the protein due to conformational changes.
2
 It has also been 
noted that leptin signaling causes phosphorylation of PTEN, thus inactivating the phosphatase 
activity, and allowing the downstream signaling through the PI3K pathway.
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Figure 1 PTEN opposes the PI3K /AKT pathway. Worby et al., Annu. Review Biochem., 2014 
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Though many studies focus on the mutations of PTEN in cancer, it is important to note 






Our attempt to identify factors that negatively regulate PTEN protein stability unraveled 
UbE2K as a potential regulator of PTEN protein. UbE2K is a component of the ubiquitin-
proteasome pathway and is specifically involved in polyubiquitination of target proteins, which 
promotes its degradation through the ubiquitin-proteasome pathway.
4
 The ubiquitin-proteasome 
pathway consists of the ubiquitin activating enzyme, E1, the ubiquitin conjugating enzyme, E2, 
and the ubiquitin ligase, E3. The first step of the ubiquitin-proteasome pathway is the activation 
of the carboxyl group of ubiquitin by E1, which involves hydrolysis of one ATP molecule. 
Consequently, a thio-ester bond is formed between a ubiquitin molecule and E1. Following this, 
the activated ubiquitin molecule is transferred to the active site cysteine residue of an E2 
enzyme. E2 then transfers the ubiquitin molecule to an  E3 ligase through a thiol linkage; this E3 
ligase in turn transfers the ubiquitin to a substrate protein that is bound to E3 ligases. 
Polyubiquitination of the substrate protein leads to its degradation through the proteasome 
pathway (Fig. 3).
5
 E2 enzymes have the unique property of selecting the lysine (Lys) residue 
through which ubiquitin chains will be formed, a determinant of the cellular fate of the substrate. 
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 Of the seven Lys residues in ubiquitin, polyubiquitination involving Lys48 leads to protein 
degradation, and 
Figure 2 PTEN is comprised of 5 functional domains. Song M, et al., Nature Reviews Molecular Cell 
Biology, 2012 
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Previous studies have shown that E2 conjugating enzymes, like UbE2K, can transfer 
ubiquitin directly to target molecules if it is catalyzed by the RING-domain of E3 ligases.
8
 
UbE2K is specifically involved in polyubiquitination of target proteins, which promotes its 
degradation through the ubiquitin-proteasome pathway (Fig. 3).
9
 The family of E2 enzymes 
contains a highly conserved ubiquitin-conjugating domain, which accommodate the ATP-
activated ubiquitin or ubiquitin-like proteins through a covalently bonded thioester connected to 
its active-site cysteine residue. It is important to note that E2 enzymes partner with specific E3 
enzymes, which determines the specificity of the downstream effector pathway on the substrate.
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Figure 3 Ubiquitin-mediated proteasome pathway. Polyubiquitination of the protein substrate leads to 




Two lysine residues, Lys289 and Lys13, have been identified on PTEN that are 
ubiquinated and regulate the nuclear localization of PTEN. Together, these two residues regulate 
PTEN import.
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 have been 
identified to promote PTEN degradation. Recently a deubiquitinase USP13, has been shown to 
protect PTEN degradation by deubiquitinating PTEN. All of these studies imply that PTEN 





There are two different types of adipose tissue in mammals: white adipose tissue (WAT) 
and brown adipose tissue (BAT). While WAT is primarily dedicated to energy storage, BAT 
plays a critical role in energy expenditure and heat generation. This energy expenditure is 
mediated primarily through mitochondrial activity.
14
 Fatty acid oxidation occurs inside the 
mitochondria, and is the process by which fatty acids are broken down to yield acetyl-CoA, 
which then enters the citric acid cycle. Other important components of fatty acid metabolism are 
specialized proteins, such as uncoupling protein 1 (UCP1). UCP1 uncouples oxidative 
phosphorylation and ATP generation by collapsing the electron gradient to generate heat 
instead.
13
 Conversely, amount of WAT regulates systemic metabolism, which has been 
implicated in various metabolic dysfunctions such as hyperglycemia, hyperlipidemia, diabetes, 
liver disease, etc. BAT is of key importance during the neonatal period for temperature control.
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An important mediator of adipogenesis is peroxisome proliferator-activated receptor 
gamma (PPARγ) – a nuclear hormone receptor that is necessary for adipogenesis by regulating 
lipid storage, lipid synthesis, and glucose sensing. It has been demonstrated that PPARγ is 
8 
expressed even before adipocyte tissue development begins; PPARγ is also expressed in adipose 
stem cells and plays a key role in stem cell proliferation and cell fate. These findings lead one to 




PTEN and Adipogenesis 
As stated previously, the major role of PTEN is to inhibit the PI3K pathway. Several 
growth factors, such as insulin-like growth factors 
and insulin, activate the PI3K pathway and its 
downstream signaling events, including activation 
of Akt . This activation of Akt induces a complex 
cascade of reactions which leads to FOXO1 
phosphorylation and its retention in the cytoplasm, 
thereby inhibiting its activity. It is important to 
note that the Foxo1 transcription factor along with 
the transcriptional co-activator, PGC1α, regulate 
the transcription of UCP1 protein. Increase in 
PTEN level will lead to inhibition of Akt, which 
in turn will activate FOXO1. PGC1α is expected to activate UCP1 transcription, thereby 
uncoupling oxidative phosphorylation and ATP generation in the mitochondria (Fig. 4).  
In a recent study, Ortega-Molina et al. (2012) generated Pten transgenic (Pten
tg
) mice by 
inserting Bacterial Artificial Chromosome clone (127kb) containing complete murine PTEN 
gene. The transgenic mice showed a 2-fold increase in PTEN level. The Pten
tg
 mice have low 
body fat, increased energy expenditure, lower serum leptin and cholesterol levels, smaller 
Figure 4 Role of PTEN in the metabolic pathway 
utilized in brown adipose tissue. Ortega-Molina et al. 
Cell Metabolism, 2012 
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adipocytes, dense and intensely colored BAT, and high uncoupling protein 1 (UCP-1) in BAT. 
UCP-1 uncouples mitochondrial oxidation and ATP production, 
thus mediating energy dissipation in BAT. The high amounts of 
UCP-1 in BAT parallels the dense phenotype observed in the 





 Not much is known about the factors that regulate PTEN protein stability; however, it has 
been shown that PTEN protein plays a critical role in regulating cellular homeostasis. Our study 
has identified several negative regulators of PTEN. One such regulator is UbE2K, which could 
be one of the key factors regulating its degradation. PTEN is highly mutated in many cancers, 
but there is still much to learn about how PTEN is regulated. This study aims to further 
investigate the mechanism mediating PTEN protein stability by studying the relationship 
between UbE2K and PTEN. 
 
Hypothesis 
We hypothesize that depletion of UbE2K will increase PTEN protein expression, both in 
vitro and in vivo. Based on the previously published studies
13
, we hypothesize that adipocyte 
specific Ube2k deletion will lead to an increase in PTEN level, thereby causing high energy 
expenditure and  a significant reduction in adipose tissue. Alteration in the mammary fat pad 
along with visceral fat depot could affect mammary gland development. In the future, we plan to 
study the role of UbE2K and PTEN in cancer and obesity to potentially find if the reciprocal 
relationship between the two has any effect specifically on mammary tumorigenesis. 
Figure 5 BAT phenotype in WT 
and PTENtg mice. Ortega-Molina 
et al., Cell Metabolism, 2012 
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Specific Aims 
Specific Aim 1: Investigate if depletion of UbE2K causes increased PTEN protein levels 
UbE2K was depleted in MCF10A, normal mammary epithelial, cells using lentivirus 
coding for UbE2K targeted shRNAs. Additionally, mice with conditional knockout alleles for 
Ube2k (EUCOMM, using the Cre-Lox recombination system in the Leone Lab) were generated 
to further understand the role of this gene in a more complex organism. 
Specific Aim 2: Investigate the in vivo phenotypes associated with adipocyte-specific Ube2k 
deletion 
We observed a significant reduction of white adipose tissue (WAT) and brown adipose 
tissue (BAT) in the whole-body Ube2k knockout mice, and hypothesized that increased Pten 
levels in Ube2k KO mice affect the normal development of adipose tissue. Ube2k was knocked 
out in the adipocytes using an adipocyte-specific cre (Adiponectin-Cre; Adipoq-Cre). These mice 
were then compared to the whole-body knockout mice to study how Ube2k regulates 
adipogenesis and mammary land development in adult mice. 
 
Study Design 
Specific Aim 1A: Investigate if depletion of UbE2K causes increased PTEN protein levels in 
vitro 
MCF10A, normal mammary epithelial cells, will be transduced with lentivirus coding for 
UbE2K targeted shRNAs to assess whether depletion of this putative PTEN regulatory gene 
affects PTEN in vitro. MCF10A cells transduced with scrambled shRNA will be used as 
negative control. PTEN and UbE2K mRNA levels in the UbE2K shRNA transduced MCF10A 
cells (MCF10A/shUbE2K) will be assessed by qRT-PCR, protein levels will be assessed by 
western blotting and compared with that in the negative control samples.  
11 




) mice will be bred with ACTFLPe mice to delete the 
lacZ-neo artificial cassette and generate the Ube2k floxed mice (Ube2k 
fl/fl
). We will generate 
whole body knockout mice (KO) for Ube2k by breeding Ube2k 
fl/fl 
mice with Sox2-Cre mice to 
study the phenotype of the KO mice 
 
Specific Aim 2A: Determine if adipocyte-specific knockout of Ube2k mimicks the whole-body 
knockout phenotype 
 Since there is a significant reduction of fat in the whole-body Ube2k KO mice, we were 
curious to see if UbE2K played an integral role in adipogenesis. Adipoq-cre; Ube2k
 fl/fl 
mice will 
be generated by breeding Ube2k 
fl/fl 
mice with Adipoq-cre mice to study their life span, body 
weight, and histological nature of the fat pads will be compared to those of the whole-body 












mice will be 




Materials and Methods 
Preadipocytes: 
Isolation: The intrascapular (ISCW) and inguinal (IGW) fat pads will be minced in sterile 
phosphate buffered saline (PBS) buffer, and digested using collagenase at 37
o
C while being 
vortexed for 100 seconds every 5 minutes for a total of 40 minutes. The digested tissue will then 
be filtered through 100um filters into Eppendorf vials and centrifuged the vials at room 
temperature at 1500rpm for 5 minutes. Upon removing the supernatant, the pellet will be 
resuspended in 1mL Dulbecco’s modified Eagle’s medium (DMEM) containing 20% fetal 




Immortalization: The preadipocytes will be immortalized by infecting the cells with the retroviral 
vector pMSe-SV40T that encodes for the SV40T antigen and selecting them with G418. 
Differentiation: Adipocyte differentiation is a 10-day time course. On day 1, the preadipocytes 
will be seeded into 6-well plates in 4mL differentiation media (DMEM, 10% FBS, 2nM insulin, 
1uM T3 filter sterilized) at a density to be confluent in four days. On day 4, cells are induced in 
4mL induction media (Differentiation media, 0.125M indomethacin, 2mg/mL dexamethasone, 
0.5M 3-isobutyl-1-methylxanthine (IBMX)). On day 6 and 8, the cells are put back into 4mL of 
fresh differentiation media. By day 10, the cells should be fully differentiated. 
Protein: The cells will be lysed using RIPA buffer (150 mM NaCl, 50 mM Tris-HCl pH 8.0, 1% 
NP-40, 0.05% Sodium Deoxycholate, 0.1% Sodium Dodecyl Sulfate). These protein extracts will 
then be separated by a 10% reduced SDS-PAGE gel, and the membrane will be probed with 
PTEN, UbE2K, and GAPDH specific antibodies and analyzed using Li-COR imaging. 
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RNA: RNA will be isolated using Trizol (Life Technologies). cDNA will be made using High 
Capacity cDNA kit (Applied Biosystems). Real-Time PCR will be performed using SYPR Green 
PCR Master Mix (Applied Biosystems). 
Immunohistochemistry: Tissues will be fixed in 4% paraformaldehyde for 48 hours and 
sectioned into 4 µm sections. Slides will then be stained with, Haemotoxylin and Eosin, HIP2 
(#8226S), PTEN (#9559L), and Ki-67 (#ab16667) antibodies. 
Oil Red O: 
Tissue: P2 pups will be sacrificed and fixed in formalin for 48 hours. Tissue will be embedded in 
OCT and sent for sectioning into 10 um frozen sections. The frozen sections will first be washed 
in tap water for three minutes. They will then be stained with filtered working Oil Red O (Stock: 
0.5% Oil Red O in 500 mL isopropanol. Working solution: 60% Oil Red O stock, 40% distilled 
water) solution. Following this first stain, the sections will be washed again in tap water for three 
minutes. The sections will then be stained with Harris hematoxylin stain for three minutes and 
then washed in tap water for 3 minutes. Finally, the sections will be placed in ammonia water for 
45 seconds, washed in tap water for 3 minutes, and mounted with aqueous mounting media. 
Cells: Once cells are differentiated, plates will be rinsed with PBS. Cells will be fixed by 
covering with PBS and formalin for 15 minutes at room temperature. Once cells are fixed, they 
will be stained with Oil Red O working solution (Stock: 0.5% Oil Red O in 100mL isopropanol. 
Working solution: 60% Oil Red O stock, 40% distilled water) for one hour at room temperature. 
Following this, the cells will be rinsed several times with distilled water to remove excess stain 




Knockout of UbE2K in mammalian cell lines causes increased PTEN protein, not mRNA, 
levels 
 We observed a marked reduction in UbeE2K mRNA and protein level in the 
MCF10A/shUbE2K cells, 
demonstrating efficient 
knockdown of UbE2K in these 
cells. We also observed a 
significant increase in PTEN 
protein levels in the UbE2K 
depleted cells compared to the 
control cells. There was no 
significant change in PTEN 
mRNA levels. Similar 
stabilization and increased half-
life of PTEN protein was 
observed in human mammary 
fibroblast depleted of UbE2K 
when treated with 
cycloheximide, an inhibitor of 
protein synthesis. These data 
suggest that knockdown of UbE2K increases the stability of PTEN protein, and not PTEN 
mRNA levels (Fig. 6).  
Figure 6 A) Knockdown of MCF10A cells using two non-
overlapping shRNAs targeted towards UbE2K mRNA resulted in 
increased both PTENC124R and endogenous PTEN protein levels 
compared to a scrambled control. There were no significant changes 
in PTEN mRNA levels. B) Knockdown of UbE2K in patient-derived 
mammary fibroblasts recapitulated these results. C) Treatment of 
these fibroblasts with cycloheximide revealed an increase in PTEN 
stability upon depletion of UbE2K. 
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Whole-body knockout of Ube2k in vivo causes significant developmental defects in mice 
We have generated mice with conditional knockout alleles for Ube2k (EUCOMM, using the Cre-
Lox recombination system in the Leone Lab, Fig. 7). We observed marked developmental 
defects in Ube2k KO mice. The KO mice are smaller at birth (Fig. 8, 9A, B) and die within 
postnatal day 2 (P2). According to Chi-square statistical analysis, these mice are not born in a 
Mendelian ratio. We harvested pups between postnatal day 1 and 2 and tissue sections were 
analyzed for gross histological changes after staining with Haematoxylin and Eosin (H&E). To 
confirm the efficiency of Sox2-Cre and the effect of UbE2K downregulation in vivo, using 
immunohistochemistry, we stained tissue sections of P2 mice with UbE2K and PTEN specific 
antibodies (Fig. 9C). Immunohistochemical analysis showed complete deletion of Ube2k in the 
KO mice. Analysis of the P2 pups showed an underdevelopment of the WAT and condensed 
BAT in the Ube2k KO mice compared to their WT littermates (Fig. 10). To investigate the extent 
to which the WAT is underdeveloped, we stained frozen tissue sections with Oil Red O stain to 
Figure 7 Targeted vector for UbE2K allele, LoxP sites were introduced flanking exon 4 of the UbE2K gene and 
a LacZ-Neo Cassette was introduced between exons 3 and 4 flanked by FRT sites.  
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detect fat globules in the tissue. We observed a complete lack of fat globules in the Ube2k KO 
mice in contrast to its abundance in WT littermates (Fig. 11). These Ube2k KO mice die between 
postnatal day 1 and 3 (P1 and P3).  
  
Figure 9 A) Ube2k+/+ at P2 B) Ube2k-/- 
at P2 C) Ube2k+/+ and Ube2k-/- at P2 
BAT and WAT IHC for UbE2K and 
PTEN 




Figure 10 WAT and BAT of Ube2k+/+ and Ube2k-/- at P2 stained with H&E 
Figure 11 WAT and BAT of Ube2k+/+ and Ube2k-/- at P2 stained with Oil Red O detected neutral 
fat globules in the WT, but not KO mice 
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Ube2k is completely knocked down in the adipose tissues and preadipocytes isolated from the 
KO mice 
WAT/ BAT: ISCW and IGW fat pads, comprised of preadipocytes that will differentiate 
into BAT and WAT, respectively, (Fig. 12A) were harvested from P2 Ube2k WT and KO mice, 
and RNA was isolated from these tissues. PTEN and PPARγ mRNA levels were assessed by 
qRT-PCR. According to these results, both PTEN and PPARγ mRNA levels increase in the KO 
mice compared to their WT littermates (Fig. 12B, C). 
Preadipocytes: ISCW and IGW fat pads were harvested from P2 Ube2k WT and KO mice 
and made into preadipocyte cell lines. Once the preadipocytes were immortalized, the cells were 
harvested for protein and RNA. Expression of Ube2k and PTEN protein and RNA levels in the 
preadipocytes were assessed by western blot and qRT-PCR, respectively. There is significant 
depletion of UbE2K protein however no significant difference in PTEN protein in Ube2k KO 
preadipocytes compared to that derived from the wild type littermates (Fig. 13A); PTEN mRNA 
levels increased in the Ube2k KO preadipocytes as compared to their wildtype littermates 
(Fig.13B). 
Figure 12 A) There is a significant decrease in  ISCW and IGW fat pad volumes in Ube2k-/- compared to Ube2k+/+  
mice at P2.  B) Ube2k deletion resulted in an increase in PTEN mRNA. C) Ube2k deletion resulted in a decrease in 
PPARγ mRNA levels 




Differentiation of the preadipocytes to adipocytes in vitro presented no difference in fat 
globule formation between Ube2k WT and KO adipocytes 
 To assess if adipocyte differentiation is regulated by UbE2K, we transduced Ube2k
fl/fl 
preadipocytes into adipocytes with either p-Babe-Hygro (pBH) empty vector and pBH-Cre to 
delete Ube2k. We next differentiated both cell lines to adipocytes and  stained the cells with Oil 
O Red. The preadipocytes differentiated into adipocytes in both the control and experimental cell 
lines; however, there was no difference in fat globule staining in either line. (Fig. 14). 
 
Figure 14 The Oil O Red staining displays neutral fat globules even in the cells lacking 
Ube2k 
Figure 13 A) Western blot analysis shows complete knockdown of UBE2K protein and no change in PTEN 
protein. B) qPCR analysis increased Pten mRNA 
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Adipocyte-specific knockout of Ube2k in vivo does not mimick the same phenotype as whole-
body knockout mice 
Hypothesizing that the whole-body Ube2k KO mice die at P2 was due to their lack of 
ability to properly regulate body heat as a result of significantly reduced fat pad volume, we were 
interested to see if knocking out Ube2k specifically in the adipocytes would induce the same 
phenotypes. The experimental Adipoq-ce; Ube2k 
fl/fl
 mice were born in a Mendelian ratio, there 
was no post-natal lethality, unlike the whole-body KO mice, and had no significant differences in 




Figure 15 A) There is no significant 
difference in body weight between 
Ube2kfl/fl and Adipoq-Cre; Ube2kfl/fl 
P2 pups B) There is no difference in 
fat globule staining between 
Ube2kfl/fl and Adipoq-Cre; Ube2kfl/fl 
P2 pups  C) There are no 
histological changes in the 
preadipocyte BAT and WAT fat 
pads between Ube2kfl/fl and Adipoq-
Cre; Ube2kfl/fl P2 pups 
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underdevelopment of the fat pads, we stained frozen tissue sections with Oil Red O stain to 
detect fat globules in the tissue. We did not observe any difference in fat globule staining in 
Adipoq-ce; Ube2k 
fl/fl
 mice compared to Ube2k 
fl/fl
 mice. Additionally, there was no histological 
difference in the BAT between the experimental and control mice; though there appears to be 
histological changes in the WAT, we have not observed underdevelopment of the fat pads at P2 
as seen in the whole-body Ube2k KO pups (Fig. 15B). 
 
Adipocyte-specific knockout of Ube2k in vivo induces increased branching in the mammary 
gland 
We observed an underdevelopment of mammary fat pads in  P2 whole-body Ube2k KO mice. 
Because of this, we were interested to see if and how the development of the mammary gland 
would be altered in mice with Ube2k knocked out specifically in the adipocytes. In one-month 
old experimental mice, mammary gland branching extends beyond the lymph node, whereas in 
control mice littermates, the branching of the mammary gland does not progress as far (Fig. 16A, 
B). Additionally, in three-month old experimental mice, there is an increase in branching 
compared to the wild type littermate controls (Fig. 16C, D). The mammary glands were stained 
with Ki-67, a cellular proliferation marker, and there was no significant difference to be found in 





Figure 16 Whole mounts of mammary glands from A) One month old Ube2kfl/fl B) One month old Adipoq-cre; 
Ube2kfl/fl C) Three month old Ube2kfl/fl D) Three month old Adipoq-cre; Ube2kfl/fl. Figures A-D stained with H&E to 
show histological nature of the mammary glands. Adipoq-cre; Ube2kfl/fl mice show further progression and increased 
branching in the mammary gland as compared to Ube2kfl/fl littermates. 
23 
  
Figure 17 Ki-67 staining for A) Ube2kfl/fl and B) 
Adipoq-Cre; Ube2kfl/f C) Vectra microscope 
quantification of percent nuclei positively stained for 
Ki-67 shows no significant difference between 
Ube2kfl/fl mice and  Adipoq-Cre; Ube2kfl/f mice 
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Discussion 
UbE2K was identified through a global shRNA screen as a negative regulator of PTEN; 
we investigated the link between PTEN and UbE2K to understand the basic mechanism by 
which UbE2K influences PTEN protein stability. 
It was seen in normal mammalian epithelial cells that knockdown of UbE2K in vitro 
causes an increase in PTEN protein levels, but no change in mRNA levels. When Ube2k was 
knocked out in vivo, the mice were not born in a Mendelian ratio, had a significant decrease in 
body weight, and did not live past P3. Much to our surprise, we noticed a phenotype in the 
preadipocyte fat pads where there was a significant decrease in fat pad volume in the Ube2k KO 
mice as compared to their WT littermates. Upon observing this phenotype, we hypothesized that 
UbE2K plays a role in adipogenesis. It is interesting to note that there is an increase in Pparγ 
mRNA levels in Ube2k KO BAT as compared to the WT littermates. Pparγ is thought to play an 
integral role in adipogenesis.
13
 It has been seen that Pparγ increases adiponectin levels
18
, and 
adiponectin is believed to enhance glucose sensitivity through fatty acid oxidation and inhibiting 
hepatic glucose production.
19
 It is possible that increasing fatty acid oxidation enhances energy 
expenditure, thus depleting the fat storage. This information leads us to believe that UbE2K may 
also have a role in this relationship between PPARγ and adiponectin. 
To further understand the function of UbE2K in adipogenesis, we generated preadipocyte 
cell lines from the ISCW and IGW preadipocyte fat pads in Ube2k KO and WT P2 pups. Upon 
differentiating the preadipocytes into adipocytes, we did not observe any difference in the 
differentiation between the KO and WT cells, nor did we notice any difference in fat globule 
staining once stained with Oil Red O. This data prompted us to believe that UbE2K may not 
directly be a critical regulator of adipogenesis, but rather it may a contributing factor to one of 
the various pathways that regulate adipogenesis. 
25 
Pursuing this idea, we knocked out Ube2k specifically in the adipocytes of mice using 
Adipoq-cre. These mice were born in Mendelian ratio, did not display differences in body 
weight, and did live beyond P3. Additionally, there were no histological changes in the 
preadipocyte ISCW and IGW fat pads as noted in the whole body KO mice. Since there was a 
significant underdevelopment of the mammary fat pads in the whole body KO mice, we studied 
the mammary glands of these Adipoq-cre mice. We observed branching that extended past the 
lymph node in the mammary glands of the one-month old experimental mice but not the control 
mice. There was also increased branching in the mammary glands of the three-month old 
experimental mice and not in the control littermates. This phenotype has huge implications in the 
scope of breast cancer, as invasion is a major element in tumorigenesis. 
Studies have shown that one of the roles of the fat pad in the mammary gland is to inhibit 
glandular branching.
20
 It has also been noted that unrestricted branching can eventually lead to 
tumorigenesis. The very nature of mammary gland development compared to tumorigenesis have 
similar components: invasion, reinitiation of cell proliferation, resistance to apoptosis, and 
angiogenesis.
21
 These factors lead one to believe that the mammary gland is a good environment 
for cancer development. It is important to note; however, that obesity is generally considered an 
increased risk factor of breast cancer due to insulin resistance, especially in post-menopausal 
women. High circulating insulin levels promote DNA synthesis and cell proliferation, which can 
lead to cancer and metastasis.
22
 These data elude to the idea that both sides of the spectrum leads 
to an increased risk for breast cancer; however, much more research will need to be conducted 
on this subject will be necessary to come to a sound conclusion on the relationship between 
Ube2k, adipogenesis and breast cancer. 
26 
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